These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3966929)

  • 1. The development of tolerance to antilipolytic agents by isolated rat adipocytes.
    Stratton GD; Myles DD; Strong P; Skidmore IF
    Biochem Pharmacol; 1985 Jan; 34(2):275-9. PubMed ID: 3966929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of tolerance to antilipolytic agents in rats.
    Myles DD; Stratton GD; Strong P; Skidmore IF
    Biochem Pharmacol; 1985 Jan; 34(2):269-74. PubMed ID: 3966928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors.
    Strong P; Coleman RA; Humphrey PP
    Prostaglandins; 1992 Jun; 43(6):559-66. PubMed ID: 1410520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilipolytic activity of viprostol, a transdermally active antihypertensive PGE2 analog.
    Crandall DL; Vu V; Lizzo FH; Davis BA; Cervoni P
    Prostaglandins; 1987 May; 33(5):767-73. PubMed ID: 2438724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antilipolytic effect of prostaglandin E2 in perifused rat adipocytes.
    Richelsen B; Pedersen SB
    Endocrinology; 1987 Oct; 121(4):1221-6. PubMed ID: 3308432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of prostaglandin E2 receptor binding is accompanied by reduced antilipolytic effects of prostaglandin E2 in isolated rat adipocytes.
    Richelsen B; Beck-Nielsen H
    J Lipid Res; 1985 Jan; 26(1):127-34. PubMed ID: 2857758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliminating the antilipolytic adenosine A1 receptor does not lead to compensatory changes in the antilipolytic actions of PGE2 and nicotinic acid.
    Johansson SM; Yang JN; Lindgren E; Fredholm BB
    Acta Physiol (Oxf); 2007 May; 190(1):87-96. PubMed ID: 17428236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of adenylate cyclase and stimulation of a high affinity GTPase by the antilipolytic agents, nicotinic acid, acipimox and various related compounds.
    Aktories K; Schultz G; Jakobs KH
    Arzneimittelforschung; 1983; 33(11):1525-7. PubMed ID: 6140925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet-activating protein discriminates the antilipolytic mechanism of insulin from that of other antilipolytic compounds.
    Kather H; Aktories K; Schulz G; Jakobs KH
    FEBS Lett; 1983 Sep; 161(1):149-52. PubMed ID: 6350045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue.
    Chatzipanteli K; Rudolph S; Axelrod L
    Diabetes; 1992 Aug; 41(8):927-35. PubMed ID: 1628767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hormone-stimulated human fat cell-lipolysis by prostaglandin E2 and its synthetic analogue sulprostrone.
    Kather H
    Prostaglandins Leukot Med; 1982 May; 8(5):525-9. PubMed ID: 6954554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age related changes in the antilipolytic effects of nicotinic acid in rat adipose tissue.
    Caparrotta L; Fassina G; Gaion RM; Tessari F
    Br J Pharmacol; 1983 Dec; 80(4):663-70. PubMed ID: 6571225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of indomethacin with the antilipolytic effect of prostaglandin E2 in rat adipocytes.
    Richelsen B
    Mol Cell Endocrinol; 1988 Jul; 58(1):85-91. PubMed ID: 3208990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lipolysis by agents acting via adenylate cyclase in fat cells from infants and adults.
    Marcus C; Sonnenfeld T; Karpe B; Bolme P; Arner P
    Pediatr Res; 1989 Sep; 26(3):255-9. PubMed ID: 2555764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antilipolytic activity of tiadenol-nicotinate in isolated fat cells: a comparison with its parent drugs.
    Gaion RM; Murari L; Cima L; Valenti P; Da Re P
    Drugs Exp Clin Res; 1985; 11(6):407-11. PubMed ID: 3836137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged treatment of adipocytes with PGE1, N6-phenylisopropyl adenosine and nicotinic acid on G-proteins and antilipolytic sensitivity.
    Green A; Milligan G; Belt SE
    Biochem Soc Trans; 1991 Apr; 19(2):212S. PubMed ID: 1909659
    [No Abstract]   [Full Text] [Related]  

  • 18. Coupling of adenylate cyclase to lipolysis in permeabilized adipocytes: direct evidence that an antilipolytic effect of insulin is independent of adenylate cyclase.
    Mooney RA; Swicegood CL; Marx RB
    Endocrinology; 1986 Nov; 119(5):2240-8. PubMed ID: 3095104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 action and binding in human adipocytes: effects of sex, age, and obesity.
    Richelsen B
    Metabolism; 1988 Mar; 37(3):268-75. PubMed ID: 3422703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of forskolin and the antilipolytic agents insulin and nicotinic acid on cyclic AMP levels in rat epididymal adipocytes.
    Fatemi SH
    Biomed Biochim Acta; 1986; 45(4):539-47. PubMed ID: 2423074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.